Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching Yao Yang

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 17, 2020
Cr(VI) induces ROS-mediated mitochondrial-dependent apoptosis in neuronal cells via the activation of Akt/ERK/AMPK signaling pathwayShih-Chang Fu, Jui-Ming Liu, Kuan-I Lee, et al.
Toxicology Letters|December 15, 2010
Arsenic induces pancreatic β-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling pathwaysTien-Hui Lu, Chin-Chuan Su, Ya-Wen Chen, et al.
American Journal of Translational Research|December 23, 2015
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcomaChing-Yao Yang, Jau-Yu Liau, Wei-Ju Huang, et al.
Journal of Cancer|August 19, 2017
Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unitYen-Fu Chen, Jou-Wei Lin, Chao-Chi Ho, et al.
Frontiers in Oncology|January 25, 2021
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry CohortSheng-Kai Liang, Li-Ta Keng, Chia-Hao Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 23, 2021
Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigenYa-Wen Yang, Chien-Chia Chen, Ching-Yao Yang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 24, 2021
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancerChia-Lin Hsu, Tzu-Hsiu Tsai, Chun-Kai Huang, et al.
BMC Cancer|March 14, 2023
Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitorsChun-Ta Huang, Chih-An Lin, Te-Jen Su, et al.
ERJ Open Research|March 12, 2024
Spray nozzle for topical anaesthesia during flexible bronchoscopy: a randomised controlled trialChun-Ta Huang, Hsiao-Chen Chou, Hao-Chun Chang, et al.
Molecular Cancer Therapeutics|April 20, 2026
Mechanisms of Acquired Resistance Following Dual EGFR/MET Inhibition in MET-Amplified EGFR TKI-Resistant Lung CancerYen-Ting Lin, Yi-Nan Liu, Ya-Chieh Hsu, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 17, 2020
Cr(VI) induces ROS-mediated mitochondrial-dependent apoptosis in neuronal cells via the activation of Akt/ERK/AMPK signaling pathwayShih-Chang Fu, Jui-Ming Liu, Kuan-I Lee, et al.
Toxicology Letters|December 15, 2010
Arsenic induces pancreatic β-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling pathwaysTien-Hui Lu, Chin-Chuan Su, Ya-Wen Chen, et al.
American Journal of Translational Research|December 23, 2015
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcomaChing-Yao Yang, Jau-Yu Liau, Wei-Ju Huang, et al.
Journal of Cancer|August 19, 2017
Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unitYen-Fu Chen, Jou-Wei Lin, Chao-Chi Ho, et al.
Frontiers in Oncology|January 25, 2021
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry CohortSheng-Kai Liang, Li-Ta Keng, Chia-Hao Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 23, 2021
Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigenYa-Wen Yang, Chien-Chia Chen, Ching-Yao Yang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 24, 2021
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancerChia-Lin Hsu, Tzu-Hsiu Tsai, Chun-Kai Huang, et al.
BMC Cancer|March 14, 2023
Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitorsChun-Ta Huang, Chih-An Lin, Te-Jen Su, et al.
ERJ Open Research|March 12, 2024
Spray nozzle for topical anaesthesia during flexible bronchoscopy: a randomised controlled trialChun-Ta Huang, Hsiao-Chen Chou, Hao-Chun Chang, et al.
Molecular Cancer Therapeutics|April 20, 2026
Mechanisms of Acquired Resistance Following Dual EGFR/MET Inhibition in MET-Amplified EGFR TKI-Resistant Lung CancerYen-Ting Lin, Yi-Nan Liu, Ya-Chieh Hsu, et al.
Pageof 19